ICD-10 Coding for Intracranial Mass(C71.9, C71.9U, C79.31)
Comprehensive guide to ICD-10 coding for intracranial masses, including benign and malignant tumors, with detailed documentation requirements and coding tips.
Complete code families applicable to Intracranial Mass
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D33.0 | Benign neoplasm of brain, supratentorial | Use when a benign supratentorial mass is confirmed by biopsy. |
|
| C79.31 | Secondary malignant neoplasm of brain | Use when a brain tumor is confirmed as metastatic from another primary site. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutIntracranial Mass
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Intracranial Mass.
Lack of molecular data documentation
Impact
Clinical: Inaccurate tumor classification, Regulatory: Non-compliance with coding standards, Financial: Potential claim denials
Mitigation
Ensure molecular testing results are included in the report, Link molecular data to diagnosis
Misusing R90.0 after biopsy confirms glioma
Impact
Reimbursement: Incorrect use can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use R90.0 only for undetermined masses pre-biopsy.
Unspecified codes
Impact
High audit risk for using unspecified codes without detailed documentation.
Mitigation
Ensure all documentation includes specific anatomical and pathological details.